Dynamiris Inc.
PrivateLast Round
Grant
May 27, 2025
Total Funding Raised
$215,000
Company Overview
Dynamiris Inc. is a health technology company that develops AI-enhanced eye-tracking software for the early diagnosis of neurological and psychiatric disorders, including Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dynamiris Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Dynamiris Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2025 | ||||
| Grant | Jul 5, 2023 |
Dynamiris Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INOVAIT | Grant |
| Centre for Aging and Brain Health Innovation | Grant |
Dynamiris Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dynamiris Inc.'s valuation, stock price, and market status.